CD79A and lymphoma: Importantly, the WHO-HEM5 excludes the use of CD79a in B-lineage assignment if the aberrant blast population meets the criteria for T-lineage assignment due to the frequent aberrant expression of CD79a in T-lymphoblastic leukemia/lymphoma.